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arguing that the aim is elimination of hyperthyroidism, that 
larger doses accomplish it with more certainty, and that the 
inevitable hypothyroidism develops under physician control. 
This approach raises a new question: In the tradeoff between 
curing hyperthyroidism and the radiation risk, how much 1311 is 
enough? To answer this, we examined the proportion cured (proportion of hyperthyroidism eliminated) for 605 patients 
with Graves' disease treated at progressively increasing fixed 
doses of 1311. 
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Between 1974 and 1979, 10,000 women with no symptoms or 
suspicion of breast cancer entered a screening project to detect 
the presence of breast cancer in asymptomatic women. Of the 
10,000 women, 181 .breast cancers were discovered in 171 
women during the five-year screening period. An additional 82 
women developed 89 breast cancers during the five-year follow-
up period. 
Although preliminary analysis of this data has been published 
both nationally and locally, 2'3 this article summarizes what we 
have learned from this project over the past decade and some 
of the unresolved issues. A similar report has been distributed 
via a final newsletter to the 10,000 women who participated. 
The Breast Cancer Detection Demonstration Projects (BCDDP) 
raised the level of capability of early detection of breast cancer 
in Hawaii and the nation. It was started here in Hawaii early in 
1974. 
Large prospective studies. Expensive long-term, random-
ized, double-blind, crossover studies are essential to settle 
some important questions, and Dr Gilbert's teams have been 
involved in a number of federally funded ones. The Coronary 
Drug Project eliminated Atromid-S and D-thyroxine as choles-
terol-lowering agents because they did more harm than good; 
the Systolic Hypertension in the Elderly Project determined that 
treatment of persons with this condition improved life expect-
ancy. This broader approach to clinical research is exemplified 
by the Breast Cancer Detection Demonstration Project (BCDDP). 
To execute the 1 0-year venture successfully required innovative 
uses of highly trained non-physician personnel, constant quality 
monitoring, a high level of team coordination, and a lookout for 
improved technology and new ideas. Among the national cen-
ters, Dr Gilbert 's was the first to insist on using rare-earth 
radiologic screens which reduced radiation by 90%; this gradu-
ally spread throughout the U.S. At the end of the project he gave 
mammographic instruments to three hospitals that agreed to 
carry out low-cost screening for women of Hawaii. 
Accomplishments 
For years we knew that some women were lucky enough to 
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have had a minute breast cancer discov-
ered and treated because it happened to 
be next to or in a biopsied lump. In the 
early 1970s, the Breast Cancer Detec-
tion Demonstration Projects brought to 
communities across the country the 
means to detect systematically these tiny, 
often microscopic, cancers through the 
use of the relatively new technique of 
breast x-ray imaging called 
mammography. Initially, personal phy-
sicians, surgeons, radiologists, and pa-
thologists had difficulty in making deci-
sions about suspected cancers that nei-
ther could be seen nor felt. However, 
increased use of mammographic units 
and technical improvements were paral-
leled by increased professional skills in 
both the diagnosis and management of 
breast cancer. Diagnosing smaller lo-
calized cancers resulted in more conser-
vative forms of treatment that offered an 
alternative to radical mastectomy. This 
new knowledge was made available to 
women, enabling them to participate 
more actively in decisions regarding 
treatment. 
In 1975, the Kodak Company devel-
oped the rare-earth screen that converts 
x-ray energy into light energy. The au-
thor (Gilbert) applied this to 
mammography in Hawaii's BCDDP the 
same year. This new technique resulted 
in an enormous reduction in radiation exposure without losing 
definition. These screens not only reduced mammographic 
radiation to I 0% of what had been a previous low level, but also 
led to similar reductions in radiation levels in other procedures, 
such as x-rays of the chest. 
While physicians improved their skills, nurses and x-ray 
technologists were trained and learned how to palpate the breast 
for possible tumors. This new skill was honed to a very high 
degree because these people received precise instruction on 
breast examination and then performed 20 or more examina-
tions daily, month after month. 
Utilizing these improved capabilities during the five years of 
screening, the BCDDP detected 181 breast cancers in women 
who were unaware that they had it. Although almost 45% of 
these cancers could be felt with the fingertips, an additional42% 
were so small that they could be detected only by mammography. 
In any screening program, the first screening yields the largest 
number of cancers: 55 women of the 10,000 in the Hawaii 
project were found to have breast cancer during the first screen-
ing round (which took two years) and 41 during the second 
round. An average of 30 women were diagnosed annually 
thereafter, bringing the total to 181. 
as often as every 12 months, but, so far, a 12-month interval 
between examinations has not been accepted by the majority of 
physicians or by women. Ten out of 11 women feel that x-ray 
examinations are probably too hazardous and too expensive to 
be worth the potential benefit. How often to have screening 
mammograms will depend on individual circumstances and the 
willingness of both individuals and society to pay for such 
examinations. 
The true cost of a set of screening mammograms, under 
optimal conditions, is close to $50. However, the chances of 
finding a cancer in women at random risk are only about two out 
of 1,000. It ends up costing society approximately $25,000 per 
discovered breast cancer in women who have no signs or 
symptoms! This figure includes, in addition to screening 
mammograms, costs such as biopsies for false positives, extra 
office visits, and so forth, which amount to an average of about 
10 times the initial mass screening cost. Obviously, we still need 
better ways to identify women at increased risk, and we need 
better and less expensive ways of detecting breast cancer, 
especially early and potentially curable breast cancer. Most of 
all, we need to know how to prevent breast cancer, which is only 
a faint hope at present. 
There is no question that mammography is a screening tech-
nique that can save lives. In these women, diagnosed with very 
early breast cancer, the five-year survival rate is 96%. This is 
very much better than the five-year survival rate of 71% in 
women with larger cancers and cancers that have spread to the 
lymph nodes. 
What Can a Woman Do? 
False Negatives and False 
Positives 
Screening techniques still are not per-
fect. Even with the best available skills 
and technology, and screening as fre-
quent! y as every year, 13% of these 181 
cancers were undetectable at screening 
but became evident within a year. At the 
same time, a high percentage of breast 
biopsies or aspirations, done as a conse-
quence of the screening, turned out to be 
negative for cancer. Therefore, some 
women who ultimately are proven to be 
free of breast cancer may, because of 
suspicious findings on palpation or 
mammography, undergo emotional 
stress and the expense of biopsy, only to 
discover that the abnormal finding is not 
a cancer. On the other hand, a normal 
mammogram or a negative aspiration or 
biopsy may greatly allay fears about the 
presence of breast cancer. 
Screening Intervals 
The question of what is the appropri-
ate interval between mammographic ex-
aminations still needs further evalua-
tion. Recent studies in the Netherlands 
have shown an improved five-year sur-
vi val rate, when screening mammograms 
were done 18 to 24 months apart. Of 
course, more cases could be diagnosed 
at an earlier stage if screening were done 
Until we can answer precisely the question of prevention, 
women can, for now, reduce the risk of breast cancer by 
following a general guideline for good health. Substances that 
are known to have detrimental effects on general health should 
be avoided. For example, it is known that fat women and women 
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who eat a high-fat diet are more apt to develop breast cancer. 
This suggests that a balanced diet without excessive calories, 
particularly as fats and oils, may not only benefit total well-
being but also result in lowering the risk for breast cancer. 
Regular exercise and recreation contribute to weight control by 
burning up calories and providing a means of managing stress. 
Ineffectual management of stress does lead to overeating. 
Affordability of Screening Mammography 
The cost of mass screening for breast cancer is, in our opinion, 
still too high. As stated above, the actual cost of taking and 
interpreting a set of screening mammograms under nearly 
optimal conditions is about $50. By contrast, the cost of diagnos-
tic mammography (when there is a suspicion of cancer) is about 
twice as much as screening mammography, but is often covered 
in part by insurance plans. The answer to high cost is neither 
government subsidy nor insurance coverage. Either course 
would merely shift costs, rather than reduce them. 
Several factors influence the cost and hence the affordability 
of screening examinations for breast cancer. First and foremost, 
the cost of the test itself: Not only is the mammography equip-
ment expensive ($70,000 or so), but so are the necessary services 
of highly trained personnel. Additionally, there are the expenses 
involved in following up suspicious findings, which often prove 
to be benign. Second, the frequency of screening: Annual 
screening can be more than a lot of women can afford. Finally, 
the site: The track record suggests that low-cost screening 
services are more likely to be available in a nonhospital setting 
or a facility that is specially set up for 
such services, utilizing volunteer help 
and other community support mecha-
bodies. Palpation and mammographic examinations of good 
quality require proper training, proper maintenance of the 
mammographic unit and monitoring of radiation, proper posi-
tioning of the screenee and processing of film, interpretation of 
films, and followup of suspicious findings. Moreover, the qual-
ity of the procedure depends heavily on the number of exams 
performed daily. Thus, a facility that keeps its acumen finely 
honed by a large volume of cases would be the place to have a 
screening done. 
Although research will proceed on the question of optimal 
frequency and other issues, we feel that screening mammography 
should be offered to the public, while efforts to lower cost and 
improve efficiency continue. 
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nisms, rather than a hospital or a private 
radiological laboratory. 
Another factor to be considered is that 
the lack of any effective method of iden-
tifying women at high risk means that 
all women must be considered as at risk. 
Although there is a relatively high prob-
ability of a woman developing breast 
cancer during her lifetime (one in 11), 
there is a relatively low probability of 
her developing it in any one year (one in 
400). Therefore, the ideal screening test 
for a disease such as this one would have 
to be very inexpensive so that it can be 
utilized repeatedly by all women over 
age 40. Unfortunately, such a test is not 
yet available. However, using the tests 
we do have, the BCDDP has demon-
strated several cost-effective techniques 
of screening that reduce costs and in-
crease quality at the same time. 
Sleeping Problem? 
The BCDDP has shown that trained, 
non-physician examiners can perform 
screening breast examinations very well. 
Specially trained technologists can dis-
tinguish normal mammograms from ab-
normal ones, thus permitting the radi-
ologist to focus his attention on the 
abnormal ones. Women appreciate the 
opportunity that is also provided, to learn 
breast self-examination on their own 
Daytime sleepine and other sleep related problems are com-
mon and often go unrecognized. Untreated they impair the qual-
ity of life, may preclispose to work related and traffic accident 
and lead to serious medical complications. Loud snoring asso-
ciated with breathing difficulties, frequent leg movements, poor 
quality of sleep, morning headache and dry mouth and need to 
frequemly nap are just a few of the symptoms. Many sleep 
disorders can be diagnosed and effectively treated. 
Thomas McNorton 
M.D. 
Neurology. Clinical Neurophysiiology 
and Sleep Disorders Medicine 
Board Certified 
HAWAII CENTER FOR SLEEP MEDICINE 
2130 South Bcretania St., Honolulu, HI 96826 
Phone: 97 3-0855 
-
HAWAII MEDICAL JOURNAL, VOL. 54. JUNE 1995 
817 
